Current Report Filing (8-k)
April 08 2016 - 5:19PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
April
6, 2016
|
Date of report (Date of earliest event reported)
|
SurModics, Inc.
|
(Exact Name of Registrant as Specified in its Charter)
|
Minnesota
|
|
0-23837
|
|
41-1356149
|
(State of Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
9924 West 74
th
Street
Eden Prairie, Minnesota
|
|
55344
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
(952) 500-7000
|
(Registrant’s Telephone Number, Including Area Code)
|
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions
(see General Instruction A.2):
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
On April 6, 2016, SurModics, Inc. (the “
Company
”) announced
enrollment of the first patient in an early feasibility study using its
proprietary SurModics SurVeil™ drug-coated balloon. A copy of a press
release announcing the foregoing is attached hereto as Exhibit 99.1 and
is incorporated herein by reference.
Item 9.01
|
Financial Statements and Exhibits.
|
(d)
|
|
Exhibits
.
|
|
|
|
|
|
|
|
Exhibit
Number
|
|
Description
|
|
|
99.1
|
|
Press Release dated April 6, 2016
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
SURMODICS, INC.
|
|
|
|
Date:
|
April 8, 2016
|
|
/s/ Bryan K. Phillips
|
|
|
|
Bryan K. Phillips
|
|
|
|
Sr. Vice President, General Counsel and Secretary
|
EXHIBIT INDEX
Exhibit
|
|
|
Number
|
|
Description
|
99.1
|
|
Press Release dated April 6, 2016
|
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Apr 2023 to Apr 2024